DIMAND ΑΝΩΝΥΜΗ ΕΤΑΙΡΕΙΑ ΑΞΙΟΠΟΙΗΣΗΣ ΚΑΙ ΕΚΜΕΤΑΛΛΕΥΣΗΣ ΑΚΙΝΗΤΩΝ ΚΑΙ ΚΑΤΑΣΚΕΥΩΝ ΥΠΗΡΕΣΙΩΝ ΚΑΙ ΣΥΜΜΕΤΟΧΩΝ financials
DIMAND ΑΝΩΝΥΜΗ ΕΤΑΙΡΕΙΑ ΑΞΙΟΠΟΙΗΣΗΣ ΚΑΙ ΕΚΜΕΤΑΛΛΕΥΣΗΣ ΑΚΙΝΗΤΩΝ ΚΑΙ ΚΑΤΑΣΚΕΥΩΝ ΥΠΗΡΕΣΙΩΝ ΚΑΙ ΣΥΜΜΕΤΟΧΩΝ
213800DX7SOSSEJBS561 | Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | €28.4M | €9.4M |
| Other income | €227.0K | €802.7K |
| Employee benefits expense | €4.3M | €4.1M |
| Depreciation & amortisation | €427.6K | €331.8K |
| Operating profit (EBIT) | €23.1M | €18.4M |
| Finance costs | €3.1M | €2.0M |
| Profit before tax | €54.5M | €17.0M |
| Income tax expense | €3.1M | €3.8M |
| Profit for the year | €51.5M | €13.2M |
| — attributable to NCI | €14.5M | €0 |
| Total comprehensive income | €51.5M | €13.2M |
| Per share | ||
| Basic EPS | €1.99 | €0.71 |
| Diluted EPS | €1.99 | €0.71 |
| Free cash flow / share | €0.01 | €-0.44 |
| Cash flow statement | ||
| Cash generated from operations | €4.6M | -€6.4M |
| Net cash from operating activities | €222.6K | -€8.2M |
| Income taxes paid | €3 | €3.0K |
| Net cash from investing activities | -€15.2M | -€20.8M |
| Purchase of PP&E (capex) | €43.0K | €35.2K |
| Purchase of intangibles | €0 | €1.8K |
| Net cash from financing activities | €40.9M | €31.4M |
| Proceeds from borrowings | €82.1M | €40.3M |
| Repayments of borrowings | €40.8M | €6.4M |
| Lease liability payments | €388.1K | €438.6K |
| Balance sheet | ||
| Total assets | €299.8M | €259.0M |
| Non-current assets | €237.0M | €172.8M |
| Property, plant & equipment | €908.3K | €1.2M |
| Current assets | €62.8M | €86.2M |
| Inventories | €47.8K | €50.4M |
| Trade & other receivables | €24.5M | €19.5M |
| Cash & equivalents | €38.3M | €12.4M |
| Total equity | €192.9M | €133.6M |
| — attributable to owners | €172.6M | €133.6M |
| Non-controlling interests | €20.3M | €0 |
| Non-current liabilities | €64.4M | €45.9M |
| Long-term borrowings | €53.0M | €37.6M |
| Current liabilities | €42.5M | €79.5M |
| Trade & other payables | €21.7M | €35.6M |
| Deferred tax liabilities | €8.1M | €6.9M |
| Derived metrics | ||
| Free cash flow | €179.6K | -€8.2M |
| Operating margin | 81.4% | 195.8% |
| Net margin | 181.1% | 140.7% |
| Return on equity | 26.7% | 9.9% |
| Cash conversion ratio | 0.00× | -0.62× |
| Capex coverage | 5.18× | -232.98× |
| Other reported items | ||
| Adjustments For Amortisation Expense | €2.8K | €2.5K |
| Adjustments For Decrease Increase In Inventories | -€8.6M | -€47.8K |
| Adjustments For Decrease Increase In Trade and Other Receivables | -€123.1K | -€7.3M |
| Adjustments For Depreciation Expense | €424.7K | €329.3K |
| Adjustments For Finance Income Cost | -€3.1M | -€1.9M |
| Adjustments For Gain Loss On Disposal of Investments In Subsidiaries Joint Ventures and Associates | €14.9M | €1.8M |
| Adjustments For Gains Losses On Fair Value Adjustment Investment Property | €11.3M | €19.3M |
| Adjustments For Increase Decrease In Trade and Other Payables | €15.1M | €3.4M |
| Adjustments For Provisions | €18.7K | €47.6K |
| Adjustments For Sharebased Payments | €828.4K | €0 |
| Adjustments For Undistributed Profits of Investments Accounted For Using Equity Method | €34.5M | €552.0K |
| Cash Advances and Loans Made To Related Parties | €4.5M | €46.0K |
| Cash Flows From Used In Operations Before Changes In Working Capital | -€1.8M | -€2.5M |
| Changes In Inventories of Finished Goods and Work In Progress | €4.0M | €0 |
| Comprehensive Income Attributable To Noncontrolling Interests | €14.5M | €0 |
| Comprehensive Income Attributable To Owners of Parent | €37.0M | €13.2M |
| Current Borrowings and Current Portion of Noncurrent Borrowings | €20.8M | €43.9M |
| Current Tax Liabilities Current | €179 | €179 |
| Deferred Tax Assets | €431.6K | €435.1K |
| Equity and Liabilities | €299.8M | €259.0M |
| Finance Income | €79.9K | €114.0K |
| Gains Losses On Disposals of Investment Properties | €0 | €65.0K |
| Gains Losses On Disposals of Investments | €14.9M | €1.8M |
| Gains Losses On Fair Value Adjustment Investment Property | €11.3M | €19.3M |
| Gains Losses On Financial Assets At Fair Value Through Profit Or Loss | €0 | €0 |
| Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss Trade Receivables | €19.5K | €133.0K |
| Income Tax Relating To Remeasurements of Defined Benefit Plans of Other Comprehensive Income | €3.3K | -€4.7K |
| Increase Decrease In Cash and Cash Equivalents | €25.9M | €2.4M |
| Increase Decrease In Working Capital | -€6.4M | €3.9M |
| Increase Decrease Through Changes In Ownership Interests In Subsidiaries That Do Not Result In Loss of Control | €5.8M | — |
| Increase Decrease Through Sharebased Payment Transactions | €828.4K | — |
| Increase Decrease Through Transactions With Owners | €7.8M | -€2.0M |
| Intangible Assets Other Than Goodwill | €5.5K | €8.3K |
| Interest Paid Classified As Operating Activities | €4.4M | €1.8M |
| Investment Property | €141.8M | €117.1M |
| Investments In Joint Ventures Accounted For Using Equity Method | €87.1M | €49.3M |
| Issued Capital | €934.0K | €934.0K |
| Liabilities | €107.0M | €125.4M |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale | €0 | €3.9M |
| Noncurrent Financial Assets At Fair Value Through Other Comprehensive Income | €0 | €0 |
| Noncurrent Financial Assets At Fair Value Through Profit Or Loss | €0 | €0 |
| Noncurrent Government Grants | €1.6M | €0 |
| Noncurrent Payables | €1.4M | €1.2M |
| Noncurrent Provisions For Employee Benefits | €295.3K | €276.6K |
| Noncurrent Receivables | €6.8M | €4.8M |
| Other Adjustments To Reconcile Profit Loss | -€24.8K | -€575 |
| Other Cash Payments To Acquire Equity Or Debt Instruments of Other Entities Classified As Investing Activities | €17.0M | €15.7M |
| Other Comprehensive Income | €11.8K | -€16.7K |
| Other Comprehensive Income Before Tax Financial Assets Measured At Fair Value Through Other Comprehensive Income | €0 | €0 |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | €15.1K | -€21.4K |
| Other Expense By Nature | €7.5M | €7.5M |
| Payments For Development Project Expenditure | €20.2M | €34.8M |
| Payments To Acquire Or Redeem Entitys Shares | €0 | €2.0M |
| Proceeds From Sales of Investment Property | €0 | €8.0M |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | €0 | €2.5K |
| Profit Loss Attributable To Ordinary Equity Holders of Parent Entity | €37.0M | €13.2M |
| Property Tax Expense | €1.0M | €1.0M |
| Purchase of Investment Property | €3.4M | €19.6M |
| Purchase of Treasury Shares | — | €2.0M |
| Retained Earnings | €77.4M | €39.7M |
| Share of Profit Loss of Joint Ventures Accounted For Using Equity Method | €34.5M | €552.0K |
| Share Premium | €92.2M | €92.2M |
| Treasury Shares | €662.1K | €2.0M |
Every line item above is a fact tagged in DIMAND ΑΝΩΝΥΜΗ ΕΤΑΙΡΕΙΑ ΑΞΙΟΠΟΙΗΣΗΣ ΚΑΙ ΕΚΜΕΤΑΛΛΕΥΣΗΣ ΑΚΙΝΗΤΩΝ ΚΑΙ ΚΑΤΑΣΚΕΥΩΝ ΥΠΗΡΕΣΙΩΝ ΚΑΙ ΣΥΜΜΕΤΟΧΩΝ's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.